[Federal Register Volume 88, Number 92 (Friday, May 12, 2023)]
[Notices]
[Page 30784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-10212]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Asim A. Hameedi, M.D.; Stay of Decision and Transmittal Order

    On April 4, 2023, the Agency issued a Decision and Order revoking, 
effective May 11, 2023, Certificate of Registration No. BH6407919 
issued to Asim A. Hameedi, M.D.\1\ Asim A. Hameedi, M.D., 88 FR 21,715 
(April 11, 2023). By letter dated May 1, 2023 (letter), addressed to 
the Drug Enforcement Administration Administrator, Dr. Hameedi 
requested that the April 4, 2023 Order be vacated \2\ because, among 
other reasons, he was never served with the underlying Order to Show 
Cause. Letter, at 1. Given the content of the letter and its 
attachments, I hereby stay the revocation of Certificate of 
Registration No. BH6407919 issued to Asim A. Hameedi, M.D., pending 
further proceedings. Asim A. Hameedi, M.D., 88 FR 21,715 (April 11, 
2023).
---------------------------------------------------------------------------

    \1\ The Order also denied any pending application to renew or 
modify this registration and denied any other pending application by 
Dr. Hameedi for registration in New York.
    \2\ Dr. Hameedi also seeks to ``excuse his default'' citing to 
21 CFR 1301.43(c)(1) and (f)(3). Letter, at 1. The default 
procedures Dr. Hameedi references did not become effective until 
December 14, 2022, and do not apply to his Order to Show Cause. 87 
FR 73,246 (Nov. 29, 2022).
---------------------------------------------------------------------------

    This matter is transmitted to the Office of Administrative Law 
Judges to conduct any and all appropriate proceedings (for example, to 
determine the sufficiency of notice and/or whether good cause exists to 
justify any delay).
    It is so ordered.

Signing Authority

    This document of the Drug Enforcement Administration was signed on 
May 9, 2023, by Administrator Anne Milgram. That document with the 
original signature and date is maintained by DEA. For administrative 
purposes only, and in compliance with requirements of the Office of the 
Federal Register, the undersigned DEA Federal Register Liaison Officer 
has been authorized to sign and submit the document in electronic 
format for publication, as an official document of DEA. This 
administrative process in no way alters the legal effect of this 
document upon publication in the Federal Register.

Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2023-10212 Filed 5-11-23; 8:45 am]
BILLING CODE 4410-09-P